Research suggests that Rauwolfia serpentina and its primary active alkaloid reserpine have a documented relationship with sleep, supported by a mix of traditional use reviews, mechanistic studies, and at least one randomized controlled trial from 1971 examining reserpine's direct effects on sleep quality. Studies indicate that reserpine influences sleep architecture, including increases in REM sleep, and affects neurochemical pathways such as noradrenaline depletion and synaptic protein activity during sleep. Historical and ethnobotanical reviews consistently note the plant's traditional use in Hindu medicine for insomnia, lending cultural context to the pharmacological findings. However, the evidence base is limited by the age of the clinical trial, the mixed nature of some findings regarding sleep architecture changes, and the fact that much of the research focuses on reserpine as an isolated compound rather than the whole plant, making it difficult to draw firm conclusions about Rauwolfia supplementation specifically.
Citations from PubMed and preprint sources. Match score (0-100) reflects automated search ranking, not clinical appraisal.
| Title | Type | Year | Direction | Match |
|---|---|---|---|---|
| Disturbances of sleep and wakefulness associated with the use of antihyperten... | Review | 1987 | Mixed | 90 |
| Reserpine and sleep. | RCT | 1971 | Supports | 85 |
| [Milestones of cardiovascular therapy. IV. Reserpine]. | Review | 2007 | Supports | 82 |
| Biotechnological interventions on the genus Rauvolfia: recent trends and immi... | Review | 2019 | Supports | 80 |
| Phagocytic elimination of synapses by microglia during sleep. | Other | 2020 | Mixed | 70 |